A Multicenter, Randomized, Double-Blind Comparative Study of Efficacy, Tolerance and Safety Between Sitagliptin ,Vildagliptin and Saxagliptin After 12-week Monotherapy in Drug-naive Adult Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Saxagliptin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 Mar 2016 Planned primary completion date changed from 1 May 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 07 Nov 2013 Planned End Date changed from 1 Jun 2013 to 1 May 2014. as reported by ClinicalTrials.gov.